News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Janice M. Porter

Articles by Janice M. Porter

21 TiP Pivotal Phase 3, Randomized Controlled Trial Evaluating the Safety and Efficacy of Aminolevulinic Acid for the Real-time Visualization of Cancer Through Fluorescent Imaging During Breast-Conserving Surgery

ByEleftherios P. Mamounas, MD, MPH,Rachel E. Eisenberg,Danielle Henry,Michael P. Kahky,Marisa P. Cooke,Jennifer Durant,Michael T. Roberts,Janice M. Porter,Amy Nester,Nayana Thalanki,Kathryn Ottolino-Perry,Ralph. S. DaCosta

April 19th 2022

Latest Updated Articles

Trending on CancerNetwork

Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC

FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC

Phase 2 Trial Will Evaluate CD19 t-haNK Combo in Indolent Lymphomas

FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC

How Would the Teclistamab Combo Approval Transform Multiple Myeloma?